Merck has had a lot in the past year
Money reorganized. The Darmstadt pharmaceutical and chemical company
bought the US semiconductor supplier Versum for 5.8 billion euros
and also strengthened with the material specialist
Intermolecular. Merck CEO Stefan aims with both acquisitions
Oschmann on business with the chip and electronics industry. Here
he hopes for growth in view of the trend towards connected
Industry, increasingly powerful processors and artificial
Intelligence.
As it was in daily business in 2019, Oschmann now wants this
Report on Thursday (10 a.m.) in a conference call. After
Merck’s takeover of Versum had raised the bar: So should
sales increased by 400 million euros to 15.7 to 16.3 billion euros
climb. The Versum takeover alone will generate proceeds of 270 million
Bring euros. The deal should also be positive in operating profit
knock down. It is unclear how the corona virus affects Merck
affects – China plays a key role in Oschmann’s plans.
The purchase of Versum is also important for Merck because of the
Group in liquid crystals for smartphones and displays
Has lost ground to the Asian competition. With new ones
Technologies that involve the elaborate manufacture of
Simplify biotech medication, however, Merck earned well and
the pharmaceuticals division is also on the up. After
Oschmann intends to take over Versum in the next two years
avoid large purchases and reduce debts. The
Help sell the allergy business to Dermapharm./als/DP/fba
AXC0028 2020-03-05 / 05: 49
Copyright dpa-AFX Wirtschaftsnachrichten GmbH. All rights reserved. Redistribution, republication or permanent storage without the express prior consent of dpa-AFX is not permitted.
– ,
